Abstract
Purpose
The influence of pre-radiotherapy pain duration on post-treatment outcomes was assessed.
Methods
Patients that received palliative radiotherapy were analyzed in a prospective observational study investigating curative and palliative radiotherapy. Brief Pain Inventory data were acquired at baseline and 1, 2, and 3 months after commencing irradiation. The pain response in terms of the index pain (i.e., pain caused by the irradiated tumors) was assessed using the International Consensus Endpoint. Patients were diagnosed with predominance of other pain (POP) if non-index pain of malignant or unknown origin was present and showed a higher pain score than the index pain. Competing risk analyses were performed in which deaths without the pain endpoints were considered as competing events.
Results
Of 229 patients analyzed, 123 (54%) experienced a pain response and 43 (19%) experienced POP. Multivariable analyses using the Fine-Gray model revealed that patients with shorter pain duration (< 1 month) had higher cumulative incidence of pain response (subdistribution hazard ratio, 2.43; 95% confidence interval [CI], 1.35–4.38) and POP (subdistribution hazard ratio, 4.22; 95% CI, 1.30–13.70) compared with patients with longer pain duration (≥ 4 months). For patients with a pain duration of less than 1 month, cumulative incidence of pain response was estimated to be 69% (95% CI, 53–85%) and cumulative incidence of POP was estimated to be 15% (95% CI, 3–28%) at 1‑month follow-up.
Conclusion
Commencing palliative radiotherapy earlier may improve the probability of patients achieving a pain response, although POP may be more frequent.
Similar content being viewed by others
References
Rich SE, Chow R, Raman S et al (2018) Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiother Oncol 126:547–557. https://doi.org/10.1016/j.radonc.2018.01.003
Rutten EH, Crul BJ, van der Toorn PP et al (1997) Pain characteristics help to predict the analgesic efficacy of radiotherapy for the treatment of cancer pain. Pain 69:131–135. https://doi.org/10.1016/S0304-3959(96)03253-8
MacLeod N, Chalmers A, O’Rourke N et al (2015) Is radiotherapy useful for treating pain in mesothelioma?: A phase II trial. J Thorac Oncol 10:944–950. https://doi.org/10.1097/JTO.0000000000000499
Saito T, Tomitaka E, Toya R et al (2019) Possible dose-response relationship in palliative radiotherapy for non-bone painful lesions. Clin Oncol 31:391–398. https://doi.org/10.1016/j.clon.2019.03.042
Rudzianskiene M, Inciura A, Gerbutavicius R et al (2017) Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: A prospective randomised study. Strahlenther Onkol 193:742–749. https://doi.org/10.1007/s00066-017-1154-5
Puentedura EJ, Cleland JA, Landers MR et al (2012) Development of a clinical prediction rule to identify patients with neck pain likely to benefit from thrust joint manipulation to the cervical spine. J Orthop Sports Phys Ther 42:577–592. https://doi.org/10.2519/jospt.2012.4243
Kooijman MK, Barten DJ, Swinkels IC et al (2015) Pain intensity, neck pain and longer duration of complaints predict poorer outcome in patients with shoulder pain—a systematic review. BMC Musculoskelet Disord 16:288. https://doi.org/10.1186/s12891-015-0738-4
Taskaynatan MA, Tezel K, Yavuz F et al (2015) The effectiveness of transforaminal epidural steroid injection in patients with radicular low back pain due to lumbar disc herniation two years after treatment. J Back Musculoskelet Rehabil 28:447–451. https://doi.org/10.3233/BMR-140539
De Ridder D, Vancamp T, Lenders MW et al (2015) Is preoperative pain duration important in spinal cord stimulation? A comparison between tonic and burst stimulation. Neuromodulation 18:13–17. https://doi.org/10.1111/ner.12253 (discussion 17)
Haumann J, van Kuijk SMJ, Joosten EA et al (2019) The Association between patient characteristics and opioid treatment response in neuropathic and nociceptive pain due to cancer. J Palliat Med 22:157–163. https://doi.org/10.1089/jpm.2018.0281
Saito T, Toya R, Tomitaka E et al (2018) Predictors of pain palliation after radiation therapy for painful tumors: a prospective observational study. Int J Radiat Oncol Biol Phys 101:1061–1068. https://doi.org/10.1016/j.ijrobp.2018.04.072
Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129–138
Chow E, Hoskin P, Mitera G et al (2012) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82:1730–1737. https://doi.org/10.1016/j.ijrobp.2011.02.008
Saito T, Toya R, Tomitaka E et al (2018) Predictors of the predominance of nonindex pain after palliative radiation therapy for painful tumors. Adv Radiat Oncol 4:118–126. https://doi.org/10.1016/j.adro.2018.08.006
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
Latouche A, Allignol A, Beyersmann J et al (2013) A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol 66:648–653. https://doi.org/10.1016/j.jclinepi.2012.09.017
Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391–4400. https://doi.org/10.1002/sim.7501
Lau B, Cole SR, Gange SJ (2009) Competing risk regression models for epidemiologic data. Am J Epidemiol 170:244–256. https://doi.org/10.1093/aje/kwp107
Gray RJ (1988) A class of K‑sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141–1154
Dignam JJ, Kocherginsky MN (2008) Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26:4027–4034. https://doi.org/10.1200/JCO.2007.12.9866
Falk S, Dickenson AH (2014) Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol 32:1647–1654. https://doi.org/10.1200/JCO.2013.51.7219
Wang CK, Myunghae Hah J, Carroll I (2009) Factors contributing to pain chronicity. Curr Pain Headache Rep 13:7–11. https://doi.org/10.1007/s11916-009-0003-3
Voscopoulos C, Lema M (2010) When does acute pain become chronic? Br J Anaesth 105(Suppl 1):i69–i85. https://doi.org/10.1093/bja/aeq323
Maihofner CG, Heskamp ML (2014) Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study. Eur J Pain 18:671–679. https://doi.org/10.1002/j.1532-2149.2013.00415.x
Kosek E, Rosen A, Carville S et al (2017) Lower placebo responses after long-term exposure to fibromyalgia pain. J Pain 18:835–843. https://doi.org/10.1016/j.jpain.2017.02.434
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. All authors were involved in material preparation, data collection, and analyses. The first draft of the manuscript was written by T. Saito and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
T. Saito, K. Murotani, K. Yamaguchi, R. Toya, E. Tomitaka, T. Watakabe, and N. Oya declare that they have no competing interests.
Ethical standards
The study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Supplementary Information
Rights and permissions
About this article
Cite this article
Saito, T., Murotani, K., Yamaguchi, K. et al. Influence of pain duration on pain outcomes following palliative radiotherapy for painful tumors: the sooner the irradiation, the better?. Strahlenther Onkol 197, 916–925 (2021). https://doi.org/10.1007/s00066-021-01760-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-021-01760-x